84-1175-17 Dinitrophenol (DNP) 100ul D8060-02B

※お見積書はカートで印刷できます

冷凍

特徴

  • Asthma is a chronic lung disease characterized by airway hyper-responsiveness (AHR) to allergens, airway edema, and increased mucus secretion.
  • Increased levels of circulating IgE and IgG1 antibody and a propensity to allergic responses, atopy, are associated with the development of asthma.
  • Animal models of AHR, where control of the timing of exposure to the initiating antigen, the use of a defined allergen trigger, and genetic manipulation are likely to enhance the understanding of AHR.
  • Dinitrophenol (DNP) has long been employed as a model immunogen as a single antigen to reduce the complexity of modeling AHR.
  • One of the primary aspects of the immune response is the interaction of antigens with lymphocytes to induce the formation of antibodies, that in turn makes the antigen harmless.
  • Much of our current understanding of the antibody response to antigens has been derived by using the antibody-hapten model.
  • One known model uses the dinitrophenyl (DNP) group.
  • Immunization of many mammalian species with DNP-protein conjugates results in production of antibodies specific for DNP and the aa side chains to which it is attached.
  • DNP conjugates (DNP-KLH or DNP-BSA) are useful for the production of antibodies specific for DNP and hemocyanin or BSA.
  • DNP immunization produced a significant variation in the amount and antibody class (IgGs, IgA, IgE, IgM) among strains, and under various experimental conditions.
  • DNP preparations (purity and supplier), routes (intramuscular, intravenous, polymerized, etc), frequency of exposure (single injections, multiple etc) may induce a defined class of antibody and its level may vary as well.
  • DNP-induced antibody production has been used to assess the immune status of normal and immune compromised animals.
  • Applications:Suitable for use in ELISA.
  • Western Blot, though not tested, may potentially be used as an application.
  • Other applications not tested.
  • Recommended Dilution:ELISA: 1:1000-1:10,000Western Blot: 1:200-1:2000 using ECL
  • Optimal dilutions to be determined by the researcher.
  • Storage and Stability:Lyophilized powder may be stored at -20°C.
  • Stable for 12 months at -20°C.
  • Reconstitute with sterile PBS.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • Reconstituted product is stable for 12 months at -20°C.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
  • Further dilutions can be made in assay buffer.

仕様

  • Size:100ul
  • Host:mouse
  • Grade:Ascites
  • Purity:Ascites
  • Form:Supplied as a lyophilized powder, 0.05% sodium azide. Reconstitute with 100ul sterile PBS, pH 7.4.
  • Specificity:Recognizes DNP-modified proteins. May also react with KLH protein.
  • Isotype:IgG
  • Calc Applications Abbrev:E
  • Immunogen:DNP-(KLH)
  • Shelf Life:1year
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-1175-17
型番
D8060-02B
入り数
1個
標準価格
181,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る